
Advance Market Analytics published a new research publication on "Essential Thrombocythemia Market Insights, to 2028" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Essential Thrombocythemia market was mainly driven by the increasing R&D spending across the world. Some of the key players profiled in the study are Incyte (United States), USV Pvt Ltd (India), Teva Pharmaceutical Industries Ltd (Israel), Novartis AG (Switzerland), AstraZeneca (United Kingdom), Pfizer Inc (United States), Bristol Myers Squibb Company (United States), Shire (United States), Pharmaessentia corporation (Taiwan).